- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1373
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1373 companies
Lotus Pharmaceutical
Market Cap: NT$61.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$255.00
7D
34.6%
1Y
-5.6%
Hisamitsu Pharmaceutical
Market Cap: JP¥297.7b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,178.00
7D
-1.0%
1Y
5.5%
Denali Therapeutics
Market Cap: US$2.0b
A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
DNLI
US$13.43
7D
1.9%
1Y
-54.1%
Zhejiang Medicine
Market Cap: CN¥13.8b
Manufactures and sells life nutrition and pharmaceutical products in China.
600216
CN¥14.25
7D
-1.9%
1Y
-11.8%
Jiang Zhong PharmaceuticalLtd
Market Cap: CN¥13.7b
Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China.
600750
CN¥21.80
7D
0.9%
1Y
-1.3%
Jubilant Pharmova
Market Cap: ₹169.8b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹1,071.80
7D
-3.9%
1Y
-9.1%
ANI Pharmaceuticals
Market Cap: US$1.9b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$93.37
7D
-4.2%
1Y
60.2%
Liquidia
Market Cap: US$1.9b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$22.45
7D
-9.0%
1Y
121.4%
Porton Pharma Solutions
Market Cap: CN¥13.4b
Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.
300363
CN¥24.54
7D
-6.5%
1Y
75.0%
Caplin Point Laboratories
Market Cap: ₹165.7b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,180.35
7D
-6.0%
1Y
13.5%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$14.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.58
7D
-2.5%
1Y
177.2%
Green Thumb Industries
Market Cap: CA$2.6b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.33
7D
-4.2%
1Y
-26.3%
Tsumura
Market Cap: JP¥274.6b
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
4540
JP¥3,696.00
7D
-0.9%
1Y
-17.3%
Vitrolife
Market Cap: SEK 17.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 128.30
7D
-3.9%
1Y
-49.0%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥12.9b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥41.19
7D
-2.5%
1Y
-5.4%
Harrow
Market Cap: US$1.8b
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$46.15
7D
1.7%
1Y
4.3%
Pharma Mar
Market Cap: €1.5b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€86.80
7D
-0.6%
1Y
79.7%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.4b
Produces and sells medicines in China.
600285
CN¥22.19
7D
-0.5%
1Y
-2.1%
Guobang Pharma
Market Cap: CN¥12.4b
Engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries.
605507
CN¥22.31
7D
-1.0%
1Y
16.9%
China Resources Boya Bio-pharmaceutical GroupLtd
Market Cap: CN¥12.4b
Engages in the blood product businesses in China.
300294
CN¥24.52
7D
-2.0%
1Y
-25.5%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.4b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.70
7D
0.3%
1Y
31.0%
Consun Pharmaceutical Group
Market Cap: HK$13.5b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.90
7D
-2.1%
1Y
144.6%
Sarepta Therapeutics
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$17.72
7D
1.7%
1Y
-85.8%
Immunocore Holdings
Market Cap: US$1.7b
A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
IMCR
US$34.08
7D
2.0%
1Y
10.8%
NATCO Pharma
Market Cap: ₹153.0b
A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹842.30
7D
-4.7%
1Y
-39.1%
Bio-Thera Solutions
Market Cap: CN¥12.2b
A biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally.
688177
CN¥28.65
7D
-3.5%
1Y
31.1%
Chongqing Taiji Industry(Group)Ltd
Market Cap: CN¥12.1b
Develops, produces, and sells traditional Chinese and modern medicine products in China and internationally.
600129
CN¥21.98
7D
1.4%
1Y
-14.4%
Aurinia Pharmaceuticals
Market Cap: US$1.7b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$12.85
7D
-0.3%
1Y
79.5%
Zhejiang Hisun Pharmaceutical
Market Cap: CN¥12.0b
Engages in the research, development, production, and sale of biological and generic drugs in China.
600267
CN¥10.26
7D
-2.6%
1Y
29.2%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥12.0b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥31.60
7D
-5.2%
1Y
21.4%
Lepu Biopharma
Market Cap: HK$13.0b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.
2157
HK$7.23
7D
-4.7%
1Y
128.8%
Vera Therapeutics
Market Cap: US$1.7b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
VERA
US$26.96
7D
2.4%
1Y
-41.0%
MannKind
Market Cap: US$1.6b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$5.33
7D
-5.0%
1Y
-15.0%
Neuren Pharmaceuticals
Market Cap: AU$2.5b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$19.39
7D
-2.2%
1Y
27.0%
BioCryst Pharmaceuticals
Market Cap: US$1.6b
A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
BCRX
US$7.65
7D
-3.9%
1Y
0.9%
Twist Bioscience
Market Cap: US$1.6b
Manufactures and sells synthetic DNA-based products.
TWST
US$26.75
7D
-4.3%
1Y
-43.2%